Trial
NCT02301949
Retreatment and Its Efficiency of Thalidomide for Vascular Malformation Patients With Failure of First Course Treatment
Phase IIWITHDRAWNSAFETYConfidence: MEDIUM
Sponsor
Zhizheng Ge
Collaborators
—
Condition
Gastrointestinal Bleeding of Unknown Origin
Intervention
Thalidomide
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-04-21